2024 AGENDA

NETWORKING BREAKFAST:
BUILD COMMUNITY CONTACTS

OPENING COMMENTS FROM YOUR HOST

PANEL DISCUSSION: FUNDING FOR TREATMENT FOR RARE DISEASES

Sharpen Your Organization’s Approach to Treatments for Rare Disease with Valuable Insights on the Impact of Health Canada’s New Funding Program

INDUSTRY EXPERT: RWE FOR HEALTH TECHNOLOGY ASSESSMENTS

Improve Your HTA Submissions with Top-Notch Real World Evidence (RWE)

PANEL DISCUSSION: THE PRIVATE PAYER MARKET

Discover What Employers Need and Best Practices for Listing Your Products with Private Payers

ROUNDTABLES → DISCOVER THOUGHT-PROVOKING IDEAS

PANEL DISCUSSION: PREFERRED PHARMACY NETWORKS (PPNs)

Benefit from an Analysis of the Impact of PPNs on Patients, Drug Costs, and Efficient Market Access

NETWORKING LUNCH:
DELVE INTO INDUSTRY CONVERSATIONS

PANEL DISCUSSION: BEYOND THE TRANSITION TO BIOSIMILARS

Assess the Impact of Transitioning to Biosimilars for Patients, Payers, and Manufacturers

PANEL DISCUSSION: PATIENT SUPPORT PROGRAMS

Expand Your Understanding of the Impact PSPs Have on Patient Access, Pricing, and Healthcare Sustainability

EXHIBITOR LOUNGE:
ATTEND VENDOR DEMOS & CONSULT INDUSTRY EXPERTS

PANEL DISCUSSION: ADDRESSING DRUG SHORTAGES

Increasing the Resiliency of our Drug Supply and Supply Chain to Prevent and Mitigate Shortages

CASE STUDY: USING BIG DATA TO TARGET UNDERSERVED POPULATIONS

How AI and Big Data Can Play a Ground-Breaking Role to Ensure Equitable Access to Treatment and Pandemic Preparedness

CLOSING COMMENTS FROM YOUR HOST

CONFERENCE CONCLUDES